Hydrochloric Acid → HCID 178519481, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6]([S:11]([N:14]1[CH2:19][CH2:18][N:17]([C:20](=[O:38])[C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[C:27]3[CH:32]=[CH:31][N:30]=[C:29]([O:33]C(C)(C)C)[N:28]=3)[CH2:16][CH2:15]1)(=[O:13])=[O:12])=[CH:5]2.Cl>ClCCl.CO>[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6]([S:11]([N:14]1[CH2:15][CH2:16][N:17]([C:20](=[O:38])[C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[C:27]3[CH:32]=[CH:31][N:30]=[C:29]([OH:33])[N:28]=3)[CH2:18][CH2:19]1)(=[O:13])=[O:12])=[CH:5]2Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 1-(5-chloroindol-2-ylsulphonyl)-4-[(2-tert-butyloxypyrimidin-4-yl)benzoyl]piperazine (200 mg, 0.361 mmol) in dichloromethane and methanol (10 ml of a 4:1 mixture) was added a solution of hydrogen chloride in methanol (0.40 ml of ˜4.5 M, 1.8 mmol), and the reaction stirred at ambient temperature for 1 hr. The solvent was removed in vacuo and the residue crystallised from ethanol to give 1-(5-chloroindol-2-ylsulphonyl)-4-[(2-hydroxypyrimidin-4-yl)benzoyl]piperazine as a colourless solid.
Workup
- customThe solvent was removed in vacuo
- customthe residue crystallised from ethanol
Sources & evidence
- ORD record
- ord-c619cbd747cb418a80c6f9f93f50fbb4
- Source dataset
- uspto-grants-2004_06
- Patent number
- US06753331B1
Reaction notes
Loading…